Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Enquest delivers 'another good year' of operational performance

(Sharecast News) - Exploration and production company Enquest said on Thursday that it had delivered "another good year of operational performance" in 2023, with production averaging 43,812 barrels of oil equivalent per day, in line with the mid-point of guidance. Enquest said its daily production figures reflected high levels of uptime and maintenance schedule optimisation.

Operating costs for the year came to roughly $370.0m, better than guidance of $400.0m, with capital costs of approximately $160.0m and decommissioning costs of about $60.0m - both in line with guidance.

Net debt was cut by $236.0m year-on-year to $481.0m, while gross debt contracted $1.4bn to $795.0m.

Going forward, Enquest said it remains focused on maintaining its track record of "upstream operational excellence" and utilising its skills, tax position, and significantly de-leveraged balance sheet to drive growth through acquisition. As far as 2024 was concerned, the group issued production guidance of between 41,000 and 45,000 boepd.

Chief executive Amjad Bseisu said: "Having de-levered the business and with debt maturities reset to 2027, we now aim to build on that strong foundation, utilising our differentiated operating capability and tax assets as we pivot the business to refocus on future growth during 2024.

"Building on this excellent operational performance and by remaining disciplined in our investment decisions, we have set the foundation for a pivot to growth during 2024. The group will provide an update on shareholder return plans when we announce our final audited results in March."

As of 1015 GMT, Enquest shares were up 8.08% at 13.12p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.